Paula Gergen
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/31578_pgergen_0.jpg?itok=mKl1ias-)
Filters
Ardelyx $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Mirion Technologies $150 million registered direct offering
We advised Mirion on the offering
RxSight $50 million follow-on offering
The stock is listed on the Nasdaq Global Market
Coherus BioSciences $150 million at-the-market offering
The stock is listed on the Nasdaq Global Market
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
EDAP TMS $23 million follow-on offering
The ADSs are listed on the Nasdaq Global Market
SVB Financial $2.25 billion concurrent offerings of notes and preferred stock
The company issued senior notes due 2026 and depositary shares representing Series D and Series E perpetual preferred stock
SVB Financial Group $1.25 billion stock offering
We advised the underwriter on the equity offering
IDEAYA Biosciences $92 million follow-on offering
We advised the underwriters on the SEC-registered stock offering